Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...

After reporting a 15% sequential decline in Izervay sales for the opening quarter of this year, Astellas has reversed the ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...

On the forefront of healthcare change, turning innovative science into value for patients: Astellas at ASCO 2025 At this year ...

While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

Review quarterly and annual revenue, net income, and cash flow for Astellas Pharma Inc (ALPMF:PINX) stock through the last fiscal year.

While the Japanese employee of Astellas Pharma was indicted in August last year, the Chinese side has not disclosed details ...

Get the detailed quarterly/annual income statement for Astellas Pharma Inc. (ALPMY). Find out the revenue, expenses and profit or loss over the last fiscal year.

Astellas Pharma Inc. recently created a new role — that of chief research & development officer — and named Cambridge ...

View today's Astellas Pharma Inc. stock price and latest 4503 news and analysis. Create real-time notifications to follow any changes in the live stock price.

View the latest Astellas Pharma Inc. ADR (ALPMY) stock price, news, historical charts, analyst ratings and financial information from WSJ.